MAM
IRON icon

Marquette Asset Management’s Disc Medicine IRON Stock Holding History

Marquette Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,922
Closed -$148K – 310
2022
Q2 		$148K Buy
2,922
+713
+32% +$31.5K 0.04% 95
2022
Q1 		$92K Buy
+2,209
New +$116K 0.02% 153

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marquette Asset Management's IRON Position: Q3 2022 in Review

Marquette Asset Management sold out of Disc Medicine (IRON) in Q3 2022, closing a stake of 2,922 shares — an estimated $148K sold.

Marquette Asset Management first reported a position in IRON in Q1 2022 and held it in 2 quarters. The position peaked at $148K in Q2 2022. 44 funds tracked by Wall St. Rank hold IRON as of Q3 2022.

  • Marquette Asset Management reported no remaining Disc Medicine position as of Q3 2022 after selling out during the quarter.
  • Marquette Asset Management sold 2,922 Disc Medicine shares in Q3 2022, an estimated $148K.
  • Marquette Asset Management first reported a position in Disc Medicine in Q1 2022 and held it in 2 quarters.
  • Marquette Asset Management's Disc Medicine position peaked at $148K in Q2 2022.
  • 44 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2022.

Based on Marquette Asset Management's 13F filing for Q3 2022, filed 6 Oct 2022.